Feasibility Insights: VR Vestibular Rehabilitation

The PLOS One feasibility study published 30 July 2026 tested DizzyVR and found high adherence and promising exploratory improvements in gait and balance, while collecting verbatim interview transcripts and per-second kinematic logs for later qualitative and quantitative analysis: PLOS One.

• Sample and dates: The study enrolled 13 starters between October 2024 and January 2025 and reported ten completers, as reported in PLOS One on 30 July 2026.
• Adherence and usability: The authors reported a session adherence rate of 91.25% among completers and a mean System Usability Scale of 68.5 in July 2026.
• Safety and adverse events: PLOS One recorded that three participants (30%) reported mild simulator sickness across five sessions, representing 6.84% of completed sessions.
• Exploratory clinical signals: The PLOS One results showed a reduction in Timed Up and Go time from 9.53s to 7.34s (p = 0.002) in the pre–post comparison reported 30 July 2026.

Answer: According to the PLOS One report published 30 July 2026, the authors ran a prospective, single-arm feasibility study that combined quantitative clinical tests with semi-structured qualitative interviews.

According to the PLOS One article published 30 July 2026, the study recruited participants at Dr. López Cano Hospital and delivered eight weekly 50-minute DizzyVR sessions, with kinematic tracking recorded once per second and semi-structured interviews transcribed verbatim.

According to the PLOS One article published 30 July 2026, feasibility was defined as protocol adherence with a success threshold of 80%, usability used the System Usability Scale, satisfaction used the USEQ score, safety used the Simulator Sickness Questionnaire and an adverse event registry, and exploratory clinical outcomes included DHI, TUG, ABC, and FGA.

Answer: The PLOS One feasibility study shows that small-sample VR trials can generate rich mixed datasets that need integrated qualitative and quantitative analysis to be useful for design and clinical decisions.

According to the PLOS One article published 30 July 2026, the study delivered per-second kinematic logs, session success rates, standard clinical scales, and verbatim interviews, which together let teams triangulate usability problems, safety signals, and functional change.

According to the PLOS One article published 30 July 2026, the qualitative interviews revealed consistent themes: perceived safety with a therapist present, early simulator sickness that decreased over sessions, and reported improvements in daily activities, which UX teams should map to specific exercise blocks when iterating the design.

Answer: The PLOS One DizzyVR feasibility study shows that immersive VR trials can produce high-value mixed datasets when they combine per-second kinematics, structured clinical scales, and verbatim interviews.

Next step for researchers: According to the PLOS One article published 30 July 2026, plan randomized trials with larger and more homogeneous samples and preserve transcripts and session logs for integrated analysis.

If you want to scale that mixed-methods workflow, Evidano ingests transcripts, logs, and survey data, then produces thematic, frequency, and cross-segment analyses to speed decision-making.

Get started: Try Evidano for free.